C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 409/12 (2006.01) A61K 31/41 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2629311
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
La présente invention concerne de nouveaux composés de formule (I) ou des sels de ceux-ci, acceptables d'un point de vue pharmaceutique, qui présentent une activité d'agoniste inverse ou d'antagoniste de récepteur du glucagon, ainsi que des procédés de préparation de tels composés. Dans d'autres modes de réalisation, cette invention concerne des compositions pharmaceutiques comprenant des composés de formule (I), ainsi que des procédés d'utilisation de ceux-ci pour traiter des troubles diabétiques, d'autres troubles métaboliques liés au glucagon et des troubles similaires.
Chappell Mark Donald
Conner Scott Eugene
Hipskind Philip Arthur
Tripp Allie Edward
Zhu Guoxin
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Glucagon receptor antagonists, preparation and therapeutic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon receptor antagonists, preparation and therapeutic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonists, preparation and therapeutic uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1655001